TrialClinical drug investigation2013

A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec.

Stefan Korsatko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.